Bio-imaging refers to technologies that are used to produce anatomical or functional images of the human body. It involves the use of imaging tools such as X-ray, CT scans, ultrasound, MRI, and nuclear medicine imaging tests like PET scans. Advancements in digital imaging and computing technology have enabled healthcare professionals to visualize internal organs, tissues and anatomical structures non-invasively. The growth of the global bio-imaging market is primarily driven by rising prevalence of chronic diseases, growing geriatric population, increasing demand for non-invasive diagnostic procedures and technological advancements.
Global Bio-imaging Market is estimated to be valued at US$ 5.74 Bn in 2024 and is expected to exhibit a CAGR of 15% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the Global Bio-imaging Market are Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc., Hitachi Medical Corporation, Lantheus Medical Imaging, Inc., Covidien Pharmaceuticals, Mindray Medical International Limited., Gamma Medica Inc., Samsung Medison Co., Ltd., and Philips Healthcare. Growing demand for early and accurate diagnosis of diseases and increasing adoption of minimally invasive surgical procedures are fueling the growth of the Global Bio-imaging Market Size. Rapid technological advancements including development of molecular bio-imaging techniques with higher sensitivity and specificities is also supporting the market growth. Market Trends The two key trends in the global bio-imaging market include growing popularity of hybrid imaging systems and rising application of nanobioimaging. Hybrid imaging systems integrate PET/CT, SPECT/CT, or PET/MR imaging modalities and offer synergies between functional and anatomical imaging. They provide better diagnostic accuracy and are witnessing higher adoption. Application of nanotechnology in bio-imaging has led to the emergence of nanobioimaging which uses nano-sized probes for molecular imaging. It provides high resolution images at cellular and sub-cellular level and has potential applications in drug discovery and development. Market Opportunities Growing healthcare expenditure in emerging markets and increasing focus on theranostics which combine therapy with diagnostic capabilities present significant growth opportunities. Further, development of AI-powered solutions for improved analysis of complex bio-imaging data and multi-omics and precision medicine also present attractive opportunities over the forecast period. Impact of COVID-19 on the Global Bio-imaging Market growth The COVID-19 pandemic has significantly impacted the growth of the global bio-imaging market. During the initial months of the pandemic, most of the hospitals and healthcare facilities postponed their non-emergency medical procedures and diagnostic scans to focus on COVID-19 management. This led to cancellation or deferment of several routine and preventive bio-imaging procedures like MRI, CT, X-rays etc. Consequently, the demand and sales of bio-imaging equipment declined drastically. However, with growing severity of the pandemic, the importance of imaging modalities became more prominent for COVID-19 diagnosis, management and treatment planning. Bio-imaging equipment played a vital role in lung imaging of infected patients and monitoring disease progression. It is expected that the demand for CT scans will remain high in the coming years for COVID-19 screening as well as management of long-term effects. Another major impact of the pandemic has been the changed priorities and reallocation of healthcare resources towards pandemic management. This has led to decreased investments in new equipment, postponed equipment upgrades and delayed installation of previously purchased devices. However, with mass vaccination programs underway, the healthcare systems are gradually recovering from the COVID-19 disruptions. The deferred medical procedures are being compensated and the bio-imaging market is projected to rebound strongly. The long-term growth prospects of the market also remain positive, supported by increasing incidence of chronic and lifestyle diseases, rapidly ageing population, technological advancements and growing funding for medical research. Value concentration in the North American region for the Global Bio-imaging Market The North American region accounts for the largest share of the global bio-imaging market in terms of value. Factors such as advanced healthcare infrastructure, widespread medical insurance, rising elder population with high disease prevalence, growing focus on early disease diagnosis have been driving the North American bio-imaging industry. The region is also an early adopter of novel imaging technologies owing to high acceptance and affordability of premium products among consumers and healthcare providers. Considerable investments are being made towards research and development of advanced imaging modalities. Presence of leading global players and strong distribution network further support the market growth. It is estimated that North America will retain its dominant position in the coming years and account for over 40% share of the total global bio-imaging revenues by 2030. Asia Pacific as the fastest growing region for the Global Bio-imaging Market Asia Pacific region is poised to showcase the fastest growth in the global bio-imaging market during the forecast period. This can be attributed to increasing healthcare spending, expanding private healthcare sectors, heavy governmental investments in medical infrastructure development, rising medical tourism and burgeoning patient population. Countries like China, Japan and India are emerging as major markets owing to growing economy, rapidly developing middle-class, increasing standards of living and changing lifestyle diseases patterns. Rising disposable incomes have augmented the affordability of high-tech medical devices. Additionally, increasing partnerships between global players and local Asian manufacturers are helping to improve access to advanced imaging modalities. It is projected that Asia Pacific will exhibit an impressive CAGR and steadily gain market shares in the coming years. Get More Insights On Global Bio-imaging Market About Author: Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
0 Comments
The transcutaneous electrical nerve stimulation (TENS) market encompasses a wide range of portable devices that help treat various types of acute and chronic pain through the application of electrical pulses to the peripheral nerves. TENS devices generate low-voltage impulses that are transmitted via electrodes placed on the dermal layers of the skin directly to the sensory nerves. The gentle electrical stimulation blocks pain signals from traveling to the brain thereby offering relief from intense or long-term pain arising due to injuries, arthritis, backaches, and other medical conditions. Non-invasive and drug-free in nature, TENS devices provide a safe therapeutic approach compared to prescription pain medications.
The global transcutaneous electrical nerve stimulation market is estimated to be valued at US$ 5.23 Bn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031. Key Takeaways The growing prevalence of chronic pain disorders worldwide due to sedentary lifestyles and medical conditions has augmented the demand for cost-effective pain management solutions. According to data by the CDC, more than 20% of the global population suffers from chronic pain requiring continuous therapy. Transcutaneous Electrical Nerve Stimulation Market Size devices effectively treat various types of chronic and acute pain at lower costs than medication and injections. The rising geriatric population suffering from arthritis and other pain-related problems has led to a growth in demand for cost-effective and non-invasive pain relief options such as TENS devices. Technological advancements have enabled introduction of new wearable TENS devices that can be remotely controlled via mobile apps for enhanced convenience. Key players operating in the Transcutaneous Electrical Nerve Stimulation Market Size are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Omron Healthcare, Inc., Nevro Corp., DJO Global, Inc., Zynex Medical, COMPex, ITO Co., Ltd., Beurer GmbH, BTL, Chattanooga International. Technological developments have led to the introduction of wearable TENS devices that can be remotely controlled through smartphone apps. These smart TENS devices allow accurate tracking of therapy routines and dosage adjustments for better management of pain symptoms. Integration of biosensors in upgraded TENS devices enables continuous monitoring of vital health parameters in real-time for personalized care. Market Trends Usage of TENS along with physical therapy and exercise - Combining TENS therapy with exercise and physical therapy boosts its efficacy for pain relief. The electrical stimulation helps offset pain experienced during movement and activity resumption. Emergence of wearable TENS devices - Novel wearable TENS devices are integrated with rechargeable batteries, wireless controls, and smartphone connectivity for remote monitoring of therapy. This convenience drives their adoption. Adoption of TENS for post-operative pain relief - Usage of TENS after surgeries helps reduce dependency on oral pain medications by blocking transmission of pain signals from surgical sites. This applications boosts demand. Market Opportunities Integrating TENS devices with AI and augmented reality - Future devices may incorporate AI, augmented reality, and machine learning to provide personalized therapy. Adoption in developing countries - Latin America, Middle East, and Asia Pacific present lucrative opportunities due to growing medical tourism and awareness about pain management. Penetration in sports medicine sector - TENS is gaining recognition for pain relief in athletics and sports injuries, driving demand in this sector. Impact of COVID-19 on Transcutaneous Electrical Nerve Stimulation Market The COVID-19 pandemic has significantly impacted the growth of the transcutaneous electrical nerve stimulation market. The lockdowns and social distancing measures imposed during the pandemic disrupt supply chains and affected the production and distribution of TENS devices. Several medical facilities also postponed elective surgeries and non-essential medical procedures to focus on COVID-19 treatment. This reduced the demand for TENS devices in the short term for pain management therapies. However, the market is expected to recover post-pandemic as restrictions are lifted and medical facilities resume their regular operations. With a rise in chronic pain cases among COVID-19 recovered patients, the use of TENS devices for home-based therapies is anticipated to increase in the coming years. Manufacturers may also focus on developing remote monitoring and consulting solutions to provide TENS care to patients from home. Geographical Regions with High Concentration in Transcutaneous Electrical Nerve Stimulation Market North America dominates the global transcutaneous electrical nerve stimulation market in terms of value, accounting for the largest market share. This is attributed to the rising geriatric population, increasing incidence of neurological disorders, and a well-established healthcare system in the region. Factors such as favorable reimbursement policies for chronic pain management, new product approvals, and growing awareness about alternative therapies also contribute to the high adoption of TENS devices in the United States and Canada. Fastest Growing Regional Market for Transcutaneous Electrical Nerve Stimulation Asia Pacific is expected to be the fastest growing regional market for transcutaneous electrical nerve stimulation during the forecast period. This is due to improving healthcare infrastructure, increasing disposable incomes, heavy research focus, and growing prevalence of chronic pain conditions in developing countries such as China and India. Large patient population, rising medical tourism, favorable government policies, and expanding private sectors are providing opportunities for major market players to penetrate the Asia Pacific region. Get More Insights On Transcutaneous Electrical Nerve Stimulation Market About Author: Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191) The self-testing market provides convenient solutions for at-home health monitoring and disease screening without requiring assistance from healthcare professionals. Products in this market include glucose monitoring kits for diabetes, ovulation predictor kits, pregnancy test kits, HIV test kits, drug abuse test kits and others. These self-testing kits offer privacy and eliminate the need for visits to diagnostic centers, clinics or hospitals. The global ease of use and accurate results have increased the adoption of self-testing, especially among millennials.
The Global Self-Testing Market is estimated to be valued at US$ 25191.62 Mn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the Self-Testing Market are BNP Paribas, CVS Health, Aviva, Allianz, Humana, Cigna, Aetna, Wellcare Health Plans Inc., UnitedHealth Group Inc., and Nippon Life Insurance Company, among others.and Nippon Life Insurance Company lead the self-testing market with a diverse product portfolio and strong distribution networks. They are investing in R&D to develop novel diagnostics solutions for accurate at-home screening. Technological advancements: IoT integrated kits, mobile apps for test result analysis and portable diagnostic devices are some key technological developments streamlining self-testing. AI assistants are being designed to provide support throughout Self-Testing Market Size procedures. Growing demand: Rising awareness about early disease detection and increased adoption of self-monitoring practices are fueling demand for self-testing products. Growing population with lifestyle diseases like diabetes also necessitates self-care practices. Market Trends Preference for convenient diagnostics: Busy lifestyles and limited access to healthcare centers in some regions have increased preference for convenient self-testing kits that can be used from home. This is a major driver for market growth. Shift to digital platforms: Players are focusing on leveraging digital technologies for product demonstration, online sales of test kits and teleconsultation services. Integration of self-testing data with digital health profiles is also seen. Market Opportunities Emerging markets: There is high growth potential in emerging countries where access to healthcare is limited. Rising disposable incomes will boost adoption of self-testing solutions in these regions. New disease segments: Demand for self-testing of chronic conditions like cancer and heart diseases is expected to surge with development of reliable home-use test kits. This presents lucrative opportunities. Impact of COVID-19 on Self-Testing Market Growth The COVID-19 pandemic has significantly impacted the growth of the self-testing market globally. During the initial phase of the pandemic, the market observed a surge in demand due to the rising awareness regarding the importance of early disease detection and diagnostics from home, without visiting hospitals or diagnostic centers. This helped reduce the risk of exposure and community transmission of the virus. However, in the initial months, supply chain disruptions affected the production and distribution of self-testing kits. With time, companies scaled up their manufacturing capacities while adopting strict safety protocols. This helped stabilize the supplies in the coming months. The demand continues to remain high even in the post-pandemic scenario due to the changed consumer behavior and preference for preventive healthcare. Many expect to regularly self-test for various health parameters from the safety of their homes. This is prompting companies to invest more in research & development of easy-to-use and accurate self-testing solutions for chronic diseases, sexual wellness, drug abuse, and other areas. Telehealth and digital platforms are also playing a bigger role in enabling self-testing, online consultations, result analysis, prescription, and delivery of OTC medicines or refills. The government's support through favorable regulations is also encouraging innovation. While pricing and reliability remain important factors, the long-term outlook for the self-testing market is positive. Regional Concentration of Self-Testing Market Value In terms of value, the self-testing market witnesses high concentration in North America and Western Europe. This is attributed to the rising healthcare costs, growing preference for preventive healthcare approach, availability of advanced technologies, favorable reimbursement policies, and presence of major players in these regions. The United States accounts for the largest market share currently due to the established markets for glucose monitoring, fertility, drugs of abuse, and OTC disease testing kits. Asia Pacific is emerging as the fastest growing regional market for self-testing globally. Factors such as rising awareness, growing middle-class population, increasing healthcare expenditures, rapid urbanization, and improving access to diagnostics are aiding the market expansion. Countries like China, India, Japan, and South Korea are expected to drive the future growth momentum in the Asia Pacific region. The increasing partnership between regional companies and global players is also positively impacting the self-testing space. Regional Focus: Asia-Pacific emerging as the fastest growing region for the self-testing market majorly due to factors like rising awareness, growing middle-class population, increasing healthcare expenditures, rapid urbanization, and improving access to diagnostics in countries like China, India, Japan & South Korea. The increasing partnership between regional companies and global players is also positively impacting the self-testing space in Asia-Pacific countries. Get More Insights On Self-Testing Market Escherichia Coli Strain Market Sees Significant Growth Amid Rising Antibacterial Resistance6/20/2024 Escherichia coli is one of the most widely used organisms for the industrial production of recombinant proteins through fermentation. E. coli strains are commonly used as a chassis for metabolic engineering and protein production as their genetics, metabolism, and cultivation conditions are well characterized. E. coli strains facilitate the commercial scale production of therapeutic proteins, industrial enzymes, and biofuels. Advancements in genetic engineering techniques have enabled the rapid and precise manipulation of E. coli genomes for developing tailored strains with optimized traits. This has significantly fueled their adoption in the biopharmaceutical and industrial biotechnology industries.
The Escherichia Coli Strain Market Size uses various microorganisms that are widely used as live cell hosts for industrial scale production of recombinant Proteins through fermentation. Their genomes have been extensively studied and genetic manipulation techniques are available. The global Escherichia Coli strain market is estimated to be valued at US$ 2.27 Bn in 2024 and is expected to exhibit a CAGR of 21% over the forecast period from 2024 to 2031. Key Takeaways Key players operating in the Escherichia Coli Strain Market are Safari Club International, Cabela's, Bass Pro Shops, Remington Outdoor Company, Beretta, Hunters Hill Safaris, Weatherby, Leica, Winchester Ammunition, Orvis, Hornady, Blaser Group, Zeiss, Sako, Norma. Rising demand for biosimilars and biologics from the pharmaceutical industry has propelled the need for high-yielding E. coli production platforms. Technological advancements such as CRISPR gene editing, synthetic biology, and metabolic engineering have enabled rapid construction of customized E. coli strains with enhanced productivity and optimized cultivation conditions. Market Trends Synthetic biology approaches: Advanced gene synthesis and automated DNA assembly techniques are enabling the rapid, precise, and scalable construction of E. coli strains with tailored genome-scale modifications for diverse industrial applications. Platform strain development: Efforts towards developing versatile E. coli platform strains with desirable traits such as high yields, culture stability, and optimized regulatory networks are underway to accelerate cell line development. Market Opportunities Consolidated production platforms: There is an increased focus on engineering generalizable E. coli strains that can function as consolidated platforms for producing diverse products in a plug-and-play mode. Advanced manufacturing systems: Integration of automated fermentation systems, advanced bioreactors, real-time process monitoring technologies, and closed biomanufacturing facilities offer opportunities for accelerated, consistent and scalable production using E. coli strains. Impact of COVID-19 on Escherichia Coli Strain Market Growth The outbreak of COVID-19 pandemic has significantly impacted the growth of Escherichia Coli Strain market. Being an emerging market, the E. Coli strain market witnessed a decline in research funding for development of new products during the initial months of the pandemic. The supply chain disruptions and lockdown restrictions imposed globally had halted the production and distribution activities of E. Coli strains. This led to shortage of strains for research and clinical applications. However, with increasing focus on developing vaccines and therapeutics for COVID-19, the demand for E. Coli strains has increased significantly from 2021 onwards. Many pharmaceutical companies and research institutes are exploring E. Coli systems for recombinant protein expression of COVID-19 antigens to accelerate vaccine development efforts. Besides this, the need for rapid diagnostic testing of COVID-19 using E. Coli strains as a detection system has also boosted market growth post pandemic. Overall, while the pandemic posed initial challenges, increased R&D in coronavirus therapeutics and diagnostics has opened new growth avenues for Escherichia Coli Strain market in the future. Geographical Regions with Highest Concentration of Escherichia Coli Strain Market North America dominates the global Escherichia Coli Strain market and accounts for over 35% of total market value. Presence of large pharmaceutical companies and research institutes involved in drug discovery and development using E. Coli strains drives significant demand from the region. Within North America, the United States represents the largest market owing to conducive regulatory environment and heavy investments in life science research. Europe is the second largest regional market for E. Coli strains attributed to growing biologics manufacturing sector and increasing government funding for synthetic biology projects utilizing E. Coli systems. Fastest Growing Regions in Escherichia Coli Strain Market Asia Pacific region is poised to witness highest growth in the E. Coli Strain market during the forecast period. This is majorly contributed by expanding biopharmaceutical industries, rising biotechnology research expenditures and improving R&D infrastructure in countries like China, India and South Korea. Additionally, growing collaborations between global players and regional research institutions to establish E. Coli strain development facilities will provide impetus to market growth trajectories across Asia Pacific. Get More Insights On Escherichia Coli Strain Market Finger Splint Market will grow at highest pace owing to increasing prevalence of sports injuries6/20/2024 The finger splint market comprises splint products that are utilized for immobilizing injured fingers. Finger splints provide protection, stability, and immobilization to injured fingers. Finger splints are made up of various materials such as thermoplastics, neoprene, and metal and are available in various sizes and designs. Finger splints find wide application in treating fractures, dislocations, sprains, and other injuries of finger joints and fingers. Increasing participation in sports and rising incidence of finger injuries are major factors boosting demand for finger splints.
The Global Finger Splint Market is estimated to be valued at US$ 285.5 Mn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024 to 2031. Key Takeaways Technological advancements in Finger Splint Market Size designs with improved comfort, rigidity, and applicability have enhanced the treatment outcomes. Players are developing lightweight, customizable, and breathable finger splints made of advanced materials to provide optimal immobilization. 3D printing technology is being leveraged to manufacture customized splints based on the injury site. The growing participation in sports and rising incidence of sports injuries have boosted the demand for. According to statistics, sports injuries account for over 30 million injuries per year in the U.S. alone. The increasing risk of finger injuries during sports and other activities is a major factor driving the finger splint market. Key players operating in the Finger Splint Market Size are 3M, BSN Medical, Patterson Medical, DJO Global, Zimmer Biomet, Stryker, Smith & Nephew, Mueller Sports Medicine, Brownmed, Össur, Mabis Healthcare, Acu-Life (Health Enterprises, Inc.), Alimed, DeRoyal Industries, Orfit Industries, Tynor Orthotics Private Limited, Sam Medical Products. These players are focusing on developing advanced splint products and expanding their geographic presence globally. Market Trends - Growing demand for custom-made 3D printed splints: Technological advancements are enabling customized 3D printing of splints based on the site of injury, which offers superior comfort and immobilization compared to standard splints. - Multi-functional advanced splint designs: Players are developing multi-functional splints capable of immobilizing multiple finger joints or the thumb and finger combination in a single splint. Market Opportunities - Emerging economies in Asia Pacific and Latin America offer high growth potential for finger splint manufacturers due to rising healthcare investments and sports and outdoor recreational activities in these regions. - Adoption of telehealth for splint customization: Virtual assessments and 3D scans of the injury sites can be leveraged by companies to remotely customize and fit splints through telehealth, ensuring convenience to patients. Impact of COVID-19 on Finger Splint Market Growth The COVID-19 pandemic has adversely impacted the growth of the global finger splint market. During the peak of the pandemic in 2020-2021, the market experienced a decline in growth due to lockdowns and social distancing measures imposed worldwide. This led to less number of sports and recreational activities where finger splints are commonly used, thereby reducing the demand. Hospitals and clinics also postponed non-emergency procedures involving finger injuries and fractures to focus on critical COVID-19 patients, hampering the sales of finger splints. However, with mass vaccination drives and easing of restrictions from late 2021, the market has started recovering. As sports activities and physical participation among individuals have resumed post-pandemic, the demand for finger splints is increasing again. At the same time, healthcare facilities have also reopened for regular operations. Market players are focusing on developing innovative lightweight, flexible and customized finger splint designs to offer maximum comfort to users. Telehealth is also emerging as an important medium to provide splint consultations and fittings to patients remotely. Manufacturers need to strengthen their online distribution channels and e-commerce platforms to drive sales. Emphasis on affordable pricing strategies can further aid the market in achieving pre-pandemic growth levels over the forecast period. North America Finger Splint Market The North America region holds the largest share of the global finger splint market in terms of value. This can be primarily attributed to the high prevalence of sports injuries and fractures in the region coupled with easy availability and affordability of advanced splint products. The United States dominates the North American as well as global finger splint market with the highest number of sports-related finger procedures annually. Factors such as presence of major players, strong healthcare infrastructure, favorable reimbursement policies, rising healthcare spending and awareness among individuals have been driving the demand for finger splints in North America. The growing participation in sports and fitness activities indicates immense potential for market growth over the coming years. Innovation and new product launches catering to specific medical needs will further aid in market expansion. Asia Pacific Finger Splint Market The Asia Pacific region has been witnessed as the fastest growing market for finger splints globally. Rapidly developing economies like China and India are experiencing rising incomes, improved access to insurance coverage and modern healthcare facilities. This has positively influenced the demand for high-quality finger splints from both individual consumers and medical institutions. At the same time, the involvement of Asian countries in international sports competitions and domestic leagues is leading to more sports injuries requiring splinting and immobilization procedures. Increasing health awareness, active lifestyles and participation in recreational activities among the urban population have augmented the adoption of finger splints. Major market players are targeting countries like Japan, South Korea, Australia and Southeast Asian nations through strategic partnerships and joint ventures to leverage future opportunities. The presence of low-cost product manufacturers also ensures wider accessibility and affordability of finger splints. All these factors will continue to fuel strong market growth rates in Asia Pacific over the next decade. Get More Insights On Finger Splint Market The nasal lotion spray market has witnessed significant growth in recent years owing to the rising prevalence of allergic conditions. Nasal lotion sprays provide efficient moisturization and relief from symptoms associated with conditions such as nasal dryness, congestion, and itching. The products contain humectants that help replenish moisture in the nasal cavity. Popular nasal lotion sprays also contain antihistamines, corticosteroids and decongestants to treat allergies and nasal inflammation. Due to their convenient, non-invasive application method, nasal lotion sprays have become a preferred treatment option over invasive options such as allergy shots.
Global Nasal Lotion Spray Market is estimated to be valued at US$ 27.64 Bn in 2024 and is expected to exhibit a CAGR of 12.% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the nasal lotion spray market include Abbott, NEOGEN Corporation., Salimetrics, LLC., Oasis Diagnostics Corporation., DiaMetra, Isohelix, OraSure Technologies., Candela Medical, Quest Diagnostics. Rising awareness regarding available nasal congestion relief options and online availability of products is fueling the demand for Nasal Lotion Spray Market Size globally. Manufacturers are focused on developing more effective formulas with enhanced moisturizing and anti-inflammatory properties. The nasal lotion spray market is witnessing increasing demand from emerging economies of Asia Pacific and Latin America. Launch of affordable generic options and expanded e-commerce channels are helping drive the market growth in these regions. Major players are focusing on strategic partnerships and acquisitions to strengthen their presence across international markets. Market Drivers A key driver for the nasal lotion spray market is the increasing prevalence of allergic rhinitis and other respiratory conditions. Recent statistics estimate that over 500 million people suffer from nasal allergies globally. Conditions such as nasal dryness are also on the rise due to growing indoor air pollution levels and excessive use of air conditioning. The non-invasive nature and convenient usage of nasal lotion sprays make them a preferred treatment option for instant relief from various nasal symptoms. This is expected to further support the demand over the forecast period. PEST Analysis Political: Regulations around nasal lotion spray ingredients and safety standards can impact the market. Government initiatives to increase awareness of personal healthcare may influence demand. Economic: Consumer purchasing power and spending on healthcare affects sales. The rising cost of manufacturing can impact company profits if not passed onto consumers. Social: Growing health consciousness and focus on preventing illnesses can drive demand. However, social stigma around certain medical conditions may hinder the market. Technological: Advancements in formulation and delivery technologies help develop customized products for specific conditions. Connected devices and digital tools may enhance access and compliance. The market in terms of value is concentrated most in North America and Europe. This can be attributed to higher consumer awareness, developed healthcare infrastructure and spending power in countries like the US, Canada, Germany, UK and France. In terms of demand, the Asia Pacific region holds strong growth potential due to increasing disposable incomes, large patient pool and expanding medical services in China, India and other developing nations. The nasal spray lotion market is growing fastest in Asia due to the region's massive population size, economic development and rising health awareness. Countries like China and India are projected to offer lucrative opportunities owing to improving access to medical services as well as rising prevalence of conditions like allergies and nasal congestion. Additionally, growing exports from Asia Pacific to other developing markets in Latin America and Africa are boosting regional market share. Get More Insights On Nasal Lotion Spray Market Humira Biosimilar Market will grow at highest pace owing to increasing healthcare expenditure6/12/2024 The Humira biosimilar market is growing rapidly as biologics have revolutionized treatment paradigms for various chronic diseases. Humira is a biologic drug developed by AbbVie and is used to treat autoimmune diseases like rheumatoid arthritis, Crohn's disease, etc. Being expensive, biosimilars provide a cost-effective alternative to the originator biologic. Biosimilars have a similar quality, safety and efficacy as Humira but are more affordable. This increases accessibility and compliance to treatment.
The Global Humira Biosimilar Market is estimated to be valued at US$ 889.46 Bn in 2024 and is expected to exhibit a CAGR of 10.% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the Humira biosimilar market are Nestlé S.A., Groupe Danone, Abbott Nutrition, Mead Johnson Nutrition, The Kraft Heinz Company, Meiji Holdings Co. Ltd., Beingmate Baby & Child food Co. Ltd., Synutra International Inc., Pfizer Inc., and FrieslandCampina. N.V. The demand for Humira biosimilars is increasing rapidly due to the growing prevalence of autoimmune disorders and increasing healthcare budgets. Various technological advancements like cell line engineering and protein expression techniques have enhanced biosimilar development. The growing geriatric population susceptible to chronic diseases is driving the global Humira Biosimilar Market Size. Various government initiatives focused on enhancing biosimilar access and adoption will also propel market revenues. Advancements in recombinant DNA technology have improved the manufacturability and yield of biosimilars. Technological developments like analytical biocharacterization techniques help demonstrate biosimilarity between the originator and biosimilar products more comprehensively. This boosts physician and patient confidence in biosimilars. Market Trends Consolidation of smaller players: Large pharmaceutical companies are acquiring smaller biosimilar development firms to consolidate their market position and leverage synergies. This allows comprehensive service offerings across the development and commercialization value chain. Increasing approval pathways: Regulatory pathways for biosimilar approval are evolving with the establishment of totality-of-evidence approach. This considers the overall biosimilarity versus direct product comparisons, facilitating early entry into the market. Market Opportunities Emerging markets: Latin America, Asia Pacific, Middle East and Africa offer lucrative opportunities owing to the growing disease burden and increasing access to healthcare in these regions. Pipeline strength: A robust biosimilars pipeline with over 300 candidates in development will ensure long-term market potential beyond the forecast period with novel products in different regions/indications. Impact of COVID-19 on Humira Biosimilar Market The COVID-19 pandemic has significantly impacted the growth of the Humira biosimilar market. The lockdowns imposed across various countries led to disruptions in the production and supply chain of drugs and biologics. This created a shortage of stocks for many therapeutic drugs including Humira biosimilars. The pandemic also reduced patient visits to clinics and hospitals for the treatment of various chronic diseases like rheumatoid arthritis, psoriasis, Crohn's disease etc. which are the major target indications of Humira biosimilars. This decline in prescriptions impacted the demand for Humira biosimilars. However, post pandemic as the lockdowns were gradually lifted, the production and supply chains resumed operations. With more awareness about the management of chronic conditions, the treatment seeking behaviour of patients also improved. This led to an increase in prescriptions and demand for affordable treatment options like Humira biosimilars. Various biosimilar drug makers are also expanding their manufacturing facilities to increase production capacities and ensure stable supplies. Their strategic focus on online channels and digital platforms for product promotion are also helping regain lost market shares. In future, the rise in approvals and launch of more affordable Humira biosimilars can accelerate the market recovery post pandemic. Regions with higher Humira biosimilar market share In terms of value, North America accounted for the major share of the global Humira biosimilar market in the pre-COVID period due to large patient pool, favorable reimbursement policies, presence of key market players and approvals of various biosimilars. The launch of US commercial operations of leading biosimilar makers further strengthened the regional market penetration. Europe was the second largest regional market driven by rising healthcare expenditure, fast-track approvals for biosimilars and growing generic prescription rates in major countries like Germany, UK and Italy. Asia Pacific exhibited high growth potential led by expansion strategies of international drug makers, increasing approvals under regulations and rising healthcare spending in China and India. Fastest growing region for Humira biosimilar market Asia Pacific region is projected to grow at the fastest rate during the forecast period for the Humira biosimilar market. This is attributed to the large patient population with chronic diseases, improving access to healthcare facilities, rising healthcare standards and increasing per capita incomes in many developing Asian countries. Government initiatives to accelerate biosimilar approvals and lower drug costs are encouraging local and global biosimilar drug makers to establish manufacturing facilities in the region. India and China as leading pharmaceutical hubs offer lucrative manufacturing and commercialization opportunities. Also, favorable regulatory framework, evolving reimbursement programs and strategic collaborations between Asia Pacific and Western companies will further propel the regional biosimilar market growth. Get More Insights On Humira Biosimilar Market The Elderly Nutrition Market comprises nutritional products such as powder, pills and drinks that are specially formulated for the nutritional needs of elderly people aged over 65 years. These products provide essential macronutrients such as protein, carbohydrates and fats along with micronutrients such as vitamins, minerals and fiber. They support healthy aging by meeting the increased nutritional needs of elderly people and reducing the risk of malnutrition and obesity. The global elderly population is growing at an unprecedented rate and chronic diseases prevalence is also rising which is increasing the demand for elderly nutritional products. The elderly nutritional products industry is predicted to witness robust growth on account of the expanding aging demography, growing health consciousness and understanding of specific nutritional needs of senior citizens.
The Global Elderly Nutrition Market is estimated to be valued at US$ 29048.57 Mn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period 2024 to 2031. Key Takeaways The key players operating in the Elderly Nutrition Market are Amcor Limited, WestRock Company, Sonoco Products Company, Sealed Air Corporation, Stora Enso Oyj, Bemis Company, Inc., MULTIVAC, WS Packaging Group, Inc., Active Packaging Ltd., and ULMA Packaging, S.Coop. These players are focusing on expanding their production capacities and geographical footprint to cater to the surging global demand for Elderly Nutrition Market Size nutritional products. Growing demand: With the rapid aging of population globally, the number of persons aged 65 years or above is projected to double from 727 million in 2020 to 1.5 billion by 2050. This substantial growth of the elderly demographic will propel the demand for specific nutritional support products tailored for seniors. Technological advancement: Manufacturers are investing in research and development to introduce technologically advanced product formulations. For instance, development of easy-to-swallow formulations, unit dose sachets for convenience and inclusion of probiotics and prebiotics to enhance digestibility and bioavailability of nutrients. Market trends The demand for functional and fortified elderly nutrition products is rising globally. Manufacturers are developing products enriched with nutrients like omega-3 fatty acids, fibers, plant-based proteins and prebiotics/probiotics to address multiple health conditions commonly prevalent among seniors like arthritis, bone health issues, hypertension etc. Customization and personalization are emerging as key trends in the elderly nutrition market. Players are offering customized products tailored as per the metabolic and physiological needs of individuals based on parameters like gender, regional diet patterns, existing medical conditions etc. Market Opportunities The increasing focus on nutrition and active aging presents significant opportunities for players. Growing acceptance of malnutrition screening programs worldwide will help in early identification of at-risk geriatric population requiring targeted supplements. The Asia Pacific region offers lucrative growth prospects with rapid aging societies in China and India. Government initiatives promoting healthy aging in countries like Japan provide a positive environment for industry growth. Geographic expansion and acquisition of regional brands can help capture untapped opportunities. Impact of COVID-19 on Elderly Nutrition Market The COVID-19 pandemic has significantly impacted the growth of the global elderly nutrition market. During the initial months of the pandemic in 2020, the sales of elderly nutrition products declined considerably as social distancing norms were strictly imposed across various countries. Elders were advised to stay indoors and avoid going out for their usual grocery shopping to prevent virus exposure. Many elder care facilities also restricted visitors to curb infections. However, with rising awareness about maintaining good nutrition levels for improved immunity against viruses, the demand for elderly nutrition products picked up gradually from mid-2020. Manufacturers responded swiftly by ramping up production of easily consumable nutrition supplements like shakes, powder mixes, and instant meal replacements. They also focused on innovative packaging solutions like single-serve pouches for independent living of elders. Many companies established direct-to-home delivery channels in collaboration with eldercare organizations and pharmacies. Teleconsultation services by dieticians helped elders choose suitable nutrition plans during lockdowns. As vaccination drives progressed in 2021-2022, social restrictions eased and senior living communities reopened. But demand continued robustly boosted by heightened health-consciousness among aging populations worldwide. Value Concentration in North America and Europe In terms of value, the North America and Europe regions accounted for around 60% share of the global elderly nutrition market in 2024 owing to growing aging populations, well-established eldercare infrastructure, and higher consumer spending power. The US and major Western European countries like Germany, UK, France, and Italy have seen rapid rise in the number of people aged 65 years and above in recent decades. With higher life expectancy and lower fertility rates, these regions have emerged as important markets for specialized nutrition products catering to the dietary needs of seniors. Fastest Growth in Asia Pacific Region The Asia Pacific region has been witnessing the fastest growth in the elderly nutrition market over the forecast period. Factors like accelerating pace of population aging, improving healthcare access, rising incomes, and growing health awareness are driving heavy demand across emerging countries like China, Japan, South Korea, and India. China, in particular, is contributing significantly to regional market expansion owing to a massive aging population base. Get More Insights On Elderly Nutrition Market Sarcopenia refers to the gradual loss of skeletal muscle mass and strength associated with aging. Some key symptoms include reduced muscle strength, fatigue, slow walking speed and physical impairment. The condition is often underdiagnosed and limits mobility and independence in old age. Treatment involves regular resistance exercises, adequate protein intake and nutritional supplements containing protein, creatine and vitamins D & B12. Branched-chain amino acids supplements are also commonly prescribed. Regular strength training with weights has been shown to be most effective in improving muscle mass and function.
The Global Sarcopenia Treatment Market is estimated to be valued at US$ 3.47 Bn in 2024 and is expected to exhibit a CAGR of 9.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Sarcopenia Treatment are Yokogawa, General Electric, Rockwell Automation, MAVERICK Technologies, Emerson, Siemens, Rudolph Technologies, Honeywell International, ABB, Schneider Electric, Aspen Technology. With rising geriatric population globally, the demand for Sarcopenia Treatment Market Size drugs and supplements is increasing. Pharmaceutical companies are investing heavily in R&D to develop more effective drugs and combination therapies. Advancements in diagnostic technologies enable early detection and intervention. Biomarkers and imaging techniques help monitor treatment response more accurately. Market trends Increasing collaborations between pharma companies for drug development and marketing will be a key trend. For instance, in 2021, Boston Therapeutics teamed with Beijing-based Zhong-Mo Pharmaceuticals for developing and commercializing formulations of BC-PI's lead compound SUGARDOWN in China, Hong Kong and Macau. Another key trend is growing adoption of telehealth and remote patient monitoring approaches for geriatric patients. This improves treatment compliance and management of the condition. Market Opportunities Growth opportunities exist in developing novel anabolic agents for boosting muscle protein synthesis. Investments into nutritional supplements containing protein hydrolysates and collagen peptides also hold promise. Emerging markets in Asia Pacific and Latin America will provide lucrative opportunities for sarcopenia treatment players owing to rapidly aging populations. Launching affordable generic drug and supplement options can further aid market access in developing nations. Impact of COVID-19 on Sarcopenia Treatment Market Growth The COVID-19 pandemic has negatively impacted the growth of the sarcopenia treatment market. During the initial phase of the pandemic, strict lockdowns were imposed across various regions which limited people's movement and restricted access to healthcare services. This led to a decline in doctor visits and delayed treatment processes for many muscle-wasting conditions including sarcopenia. The fear of contracting the virus in hospitals also discouraged older adults from seeking timely healthcare, worsening the risks of sarcopenia. However, with the ease of lockdown restrictions and resumption of normal activities, the sarcopenia treatment market has started recovering. The pre-COVID scenario saw steady rise in sarcopenia cases worldwide owing to rapidly aging population. Various drugs and therapies were in development and trials to address this unmet need. However, research activities were disrupted due to shutdown of facilities and diversion of resources towards COVID-19 during the pandemic. This pause in new product development and launch set back the market growth temporarily. Now, companies have resumed their R&D with protocols to ensure safety. Telehealth and homecare have also picked up to continue patient monitoring and management in a safe way. Emphasis will be on digital healthcare solutions, remote patient management, nutrition and lifestyle modification programs to boost recovery and prevent worsening of sarcopenia amid social distancing. Collaborations between industry and research institutes will help expedite pipeline products. Overall, increased awareness about sarcopenia post pandemic and addressal of current treatment gaps will drive the market in coming years, though short-term impacts may persist. Geographical Regions with High Sarcopenia Treatment Market Value North America currently dominates the sarcopenia treatment market in terms of value, owing to high healthcare expenditure and prevalence of sarcopenia alongside obesity and sedentary lifestyles in developed countries like United States. Europe is also a major region supported by growing elderly population and availability of wide range of approved drugs. Both these developed markets have solid reimbursement mechanisms backing uptake of high-cost therapies. Asia Pacific is projected to experience fastest gains due to escalating geriatric demographics in China and India along with rising healthcare standards. Middle East and Latin America present untapped opportunities due to emerging economies, though awareness needs to be enhanced. Africa has low treatment rate currently but offers future potential with increasing life expectancy. Across globe, focus on preventive healthcare is translating to early diagnosis and management of sarcopenia. Fastest Growing Region for Sarcopenia Treatment Market Asia Pacific region is poised to witness the fastest growth in the sarcopenia treatment market during the forecast period owing to several factors. The steeply rising geriatric population, improving access to modern medicines, growing health awareness, and increasing disposable incomes are major drivers. Presence of top players is enhancing service availability. Furthermore, the economic development has prompted populace towards sedentary urban lifestyles favoring sarcopenia risk. Nations like China and India offer huge populations and emerging markets respectively. Japan already has one of the oldest populations globally demanding better sarcopenia solutions. Southeast Asian countries are industrializing rapidly. Overall, Asia Pacific presents a large prevalence base as well as demand uptake that will catapult the regional sarcopenia treatment market ahead of others on growth curve. Collaborations with key global players and researchers can fast-track the region on innovation and care provision. Get More Insights On Sarcopenia Treatment Market The global diabetic lancing device market involves medical devices used for puncturing the skin to obtain samples of capillary blood for testing blood glucose levels. These devices are crucial for self-monitoring of blood glucose levels among diabetic patients. Popular product types include push-button lancing devices, side-button lancing devices, and pressure-activated lancing devices. Diabetic lancing devices are easy-to-use, painless, and help patients effectively manage their condition. The alarming rise in diabetes cases globally is a key factor fueling demand for lancing devices for regular self-testing.
The Global Diabetic Lancing Device market is estimated to be valued at US$ 928.2 Mn in 2024 and is expected to exhibit a CAGR of 9.8% over the forecast period 2024 To 2031. Key Takeaways The Global Diabetic Lancing Device Market Size is driven by the rising prevalence of diabetes worldwide. As per estimations, around 463 million adults suffered from diabetes in 2019 and the number is predicted to increase to around 700 million by 2045. This immense patient pool requires regular self-testing, boosting demand for lancing devices. Key players operating in the Global Diabetic Lancing Device are Genteel LLC., Abbott, BD, Braun SE, F. Hoffmann-La Roche Ltd, Greiner Bio-One International GmbH, Eli Lilly and Company, Allison Medical, Inc., Diabetyk24 z o.o., i-SENS, Inc., Nipro Corporation, Medisave UK Ltd, Home Health Ltd, Medtronic, ARKRAY, Inc., Owen Mumford, and LifeScan IP Holdings, LLC. Technological developments are also supporting market growth. Key players are focusing on developing smart, wireless, and painless lancing devices integrated with various testing features. This is expected to improve compliance for self-monitoring among patients. Market Trends The demand for alternative site testing lancing devices is growing owing to its advantages. Alternative site testing offers painless blood collection from areas like forearm, thigh, calf, besides fingertips. This improves compliance for regular glucose monitoring. Advanced alternative site testing lancing devices with features like adjustable depth settings and easy calibration are gaining traction. Integration of lancing devices with apps and connectivity features is another emerging trend. Connected lancing devices automate data collection and sharing with physicians and caregivers. This eases remote monitoring and management of diabetes. Bluetooth and Wi-Fi enabled smart lancing devices are being increasingly marketed by key players. Market Opportunities Emerging economies in Asia Pacific and Latin America are a major opportunity, with growing diabetes prevalence in these regions. Favorable regulations and reimbursement policies could boost the uptake of lancing devices in these developing healthcare markets. Online sales channels and direct-to-consumer business models also offer scope for higher penetration. With increasing internet penetration, online platforms help diabetic patients conveniently purchase lancing devices and testing supplies. This presents an avenue for market participants. Impact of COVID-19 on the Global Diabetic Lancing Device Market The COVID-19 pandemic has significantly impacted the growth of the global diabetic lancing device market. During the peak of the pandemic in 2020-2021, people were avoiding visiting healthcare facilities and clinics for non-emergency care due to fear of contracting the virus. This led to delays in diagnosis and treatment monitoring of diabetes. As a result, demand for home-use diabetic lancing devices saw a surge as patients were relying more on self-monitoring of blood glucose levels at home. With vaccines roll-outs and relaxation of lockdowns from late 2021 onwards, patients gradually began visiting doctors for routine check-ups and treatment. However, the after-effects of the pandemic are still being felt in the lancing device market. The supply chain disruptions caused due to lockdowns and restrictions impacted the availability of lancing devices. This led to a rise in prices of lancing devices in the short-term. Additionally, the economic downturn due to the pandemic has also affected the purchasing power of some consumers. Going forward, as the overall healthcare system recovers, the demand for diabetic lancing devices is expected to regain momentum. However, a lasting impact of the pandemic will be the increased preference for home-use lancing devices amongst patients. Manufacturers will need to focus on developing affordable and user-friendly lancing devices that can help in self-management of diabetes and blood glucose monitoring at home in the post-COVID world. Collaborations with healthcare providers and insurers will also be important for improving access to these devices. North America dominates the global diabetic lancing device market in terms of value. This is attributed to the growing prevalence of diabetes in the region along with high adoption of technologically advanced lancing devices. Additionally, favorable reimbursements and initiatives by governments to promote self-monitoring are propelling the market in North America. The Asia Pacific region is poised to be the fastest growing market owing to rising awareness about diabetes management, increasing healthcare expenditures and presence of leading players focusing on these emerging countries. Countries like China, India and Japan will be the prime drivers of the lancing device market in the Asia Pacific region. Get More Insights On Global Diabetic Lancing Device Market |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories
All
|